Clinical Trial Update: Comparison of 0.375% Ropivacaine and 0.25% Levobupivacaine for Infraclavicular Brachial Plexus Block [Phase 4]

View source ↗

Summary

Phase 4 trial comparing 0.375% ropivacaine to 0.25% levobupivacaine for infraclavicular brachial plexus block in regional anesthesia is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Regional Anesthesia

Drugs mentioned

• Ropivacaine (Ropivacaine)
• levobupivacaine (levobupivacaine)

Snippet

Sponsor: Asan Medical Center | Conditions: Regional Anesthesia | Phase 4 | Status: COMPLETED